文献速递脑血管病外科神经重症

6-磷酸葡萄糖脱氢酶与8-异前列腺素F2α作为动脉瘤性蛛网膜下腔出血后迟发性脑缺血的潜在预测指标

Glucose-6-phosphate dehydrogenase and 8-iso-prostaglandin F2α as potential predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
PubMed 文献 · J Neurosurg · 2023-01-13

该研究纳入45例动脉瘤性蛛网膜下腔出血(aSAH)患者,在第2、4、6天用ELISA检测血浆F2-异前列腺素(F2-IsoP)和6-磷酸葡萄糖脱氢酶(G6PD)浓度,分析其与迟发性脑缺血(DCI)及预后的关系。结果显示aSAH患者F2-IsoP和G6PD浓度高于对照组(p<0.01),DCI患者F2-IsoP更高而G6PD更低(p<0.01),第2天F2-IsoP和G6PD浓度与DCI发生相关(p<0.01),第2天和第6天F2-IsoP浓度与1个月和12个月预后相关(p<0.01)。作者认为第2天mFisher分级、血浆F2-IsoP和G6PD浓度联合可能作为DCI的预测指标,并需进一步研究F2-IsoPs和抗氧化剂的治疗效用。

要点

  • aSAH患者血浆F2-IsoP和G6PD浓度高于对照组(p<0.01)。
  • DCI患者F2-IsoP浓度更高、G6PD浓度更低(p<0.01)。
  • 第2天F2-IsoP和G6PD浓度与DCI发生相关(p<0.01)。

核心结论

  • G6PD降低间接反映抗氧化反应减弱,尤其对谷胱甘肽系统。
  • DCI患者G6PD浓度低于无DCI者,可能解释F2-IsoP浓度升高。
  • 第2天mFisher分级、血浆F2-IsoP浓度和G6PD浓度联合可能作为DCI的预测指标。
  • 需进一步研究F2-IsoPs和抗氧化剂在临床实践中的治疗效用。

研究设计与样本

  • 评估45例aSAH患者,于aSAH后第2、4、6天用商品化ELISA检测F2-IsoP和G6PD浓度。
  • 分析血浆F2-IsoP和G6PD浓度及临床因素与DCI发生和aSAH预后的相关性。

主要发现

  • DCI最重要的临床预测因素为Hunt和Hess分级及改良Fisher(mFisher)分级。
  • aSAH患者血浆F2-IsoP和G6PD浓度高于对照组(p<0.01)。
  • DCI患者F2-IsoP浓度更高、G6PD浓度更低(p<0.01)。
  • 第2天血浆F2-IsoP和G6PD浓度与DCI发生相关(p<0.01)。
  • 第2天和第6天血浆F2-IsoP浓度与1个月和12个月预后相关(p<0.01)。

临床怎么用

  • 作者认为第2天mFisher分级、血浆F2-IsoP浓度和G6PD浓度联合可能作为DCI的预测指标。
  • 作者提出需进一步研究F2-IsoPs和抗氧化剂在临床实践中的治疗效用。

局限性

  • 需进一步研究F2-IsoPs和抗氧化剂在临床实践中的治疗效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delayed cerebral ischemia (DCI) is a serious complication of aneurysmal subarachnoid hemorrhage (aSAH), which is responsible for significant death and disability. The dynamic balance between the production and elimination of reactive oxygen species (ROS) in patients with DCI is suspected be shifted to favor ROS formation. The authors assessed the relationship between F2-isoprostanes (F2-IsoPs), oxidative stress biomarkers, and glucose-6-phosphate dehydrogenase (G6PD), which are responsible for nicotinamide adenine dinucleotide phosphate (NADPH) production for glutathione system function, with post-aSAH DCI. METHODS: The authors assessed 45 aSAH patients for F2-IsoP and G6PD concentration using commercial ELISA on days 2, 4, and 6 after aSAH. The authors examined the correlation between plasma F2-IsoP and G6PD concentrations and clinical factors with DCI occurrence and aSAH outcome. RESULTS: Expectedly, the most important clinical predictors of DCI were Hunt and Hess grade and modified Fisher (mFisher) grade. Plasma F2-IsoP and G6PD concentrations were greater in aSAH patients than the control group (p < 0.01). F2-IsoP concentrations were greater and G6PD concentrations were lower in patients with DCI than those without (p < 0.01). Plasma F2-IsoP and G6PD concentrations on day 2 were correlated with DCI occurrence (p < 0.01). Plasma F2-IsoP concentrations on days 2 and 6 were correlated with outcome at 1 and 12 months (p < 0.01). CONCLUSIONS: Decreased G6PD indirectly informs the reduced antioxidant response, especially for the glutathione system. G6PD concentration was lower in patients with DCI than those without, which may explain the increased F2-IsoP concentrations. mFisher grade, plasma F2-IsoP concentration, and G6PD concentration on day 2 after aSAH, in combination, may serve as predictors of DCI. Further research is necessary to investigate the therapeutic utility of F2-IsoPs and antioxidants in clinical practice.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Wiśniewski K, Popęda M, Price B, et al. Glucose-6-phosphate dehydrogenase and 8-iso-prostaglandin F2α as potential predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2023. PMID: 36640097. doi:10.3171/2022.12.JNS222332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。